Linked e-resources
Details
Table of Contents
Intro; Foreword; Preface; Acknowledgements; Contents; Editors and Contributors; 1: Lung Cancer: An Overview; 1.1 Introduction; 1.2 Subtypes of Lung Cancer; 1.3 Risk Factors; 1.4 Clinical Features; 1.5 Staging of Non-small Cell Lung Cancer; 1.6 Staging of Small Cell Lung Cancer; References; 2: Pathology of Lung Cancer; 2.1 Background; 2.2 Role of Pathologist in Todayâ#x80;#x99;s Era of Personalized Medicine; 2.3 New 2015 WHO Classification of Lung Cancer Recommendations; 2.4 Molecular Work-Up for the Lung; References; 3: Management of Lung cancer; 3.1 Introduction
3.2 Diagnosis3.3 Radiological Diagnosis; 3.4 Pathologic Diagnosis; 3.5 Staging; 3.6 Lung Cancer Staging System [9] (Table 3.1); 3.7 Management; 3.7.1 Early-Stage Lung Cancer; 3.7.1.1 Surgery; 3.7.1.2 Nonsurgical Management; Radiotherapy and Stereotactic Body Radiotherapy (SBRT); Radiofrequency Ablation; Adjuvant Chemotherapy; Adjuvant Radiotherapy; 3.7.2 Management of N2 Disease; 3.7.3 Management of Locally Advanced Unresectable Lung Cancer; 3.7.4 Management of Stage IV Disease; 3.7.5 Small Cell Lung Cancer; References; 4: Radiological Imaging in Lung Cancer
4.1 Introduction4.2 Imaging of the Primary Tumour; 4.2.1 CT Features of Mediastinal Invasion on CT; 4.2.2 Superior Sulcus Tumours (Pancoastâ#x80;#x99;s Tumours); 4.3 Imaging of Nodal Disease; 4.3.1 Nodal Sampling; 4.4 Imaging of Metastatic Disease; 4.5 Restaging of Tumours; 4.6 Imaging of Recurrent Disease; References; 5: 18F-FDG PET/CT in Lung Cancer; 5.1 Introduction; 5.2 Role of 18F-FDG PET/CT in the Evaluation of Solitary Pulmonary Nodule; 5.3 Staging of NSCLC; 5.3.1 T Staging; 5.3.2 N Staging; 5.3.3 M Staging; 5.4 Radiotherapy (RT) Planning
5.5 Prediction of Response and Treatment Response Evaluation5.6 Restaging/Recurrence; 5.7 Prognostication; 5.8 Small Cell Lung Cancer (SCLC); References; 6: 18F-FDG PET/CT: Normal Variants, Artifacts, and Pitfalls in Lung Cancer; 6.1 Introduction; 6.2 Normal Variants, Artifacts, and Pitfalls in Lung Cancer; 6.2.1 Technical Artifacts; 6.2.2 Various False Positives Due to Infection and Inflammation; 6.2.3 Incidental Findings; 6.2.3.1 Asymmetrical Vocal Cord Uptake; 6.2.4 Benign Etiologies Mimicking Distant Metastases in Lung Cancer
6.2.5 False-Negative Neoplastic PathologyReferences; 7: Physics of PET and Respiratory Gating; 7.1 PET Physics; 7.2 Reconstruction; 7.3 PET Tracers; 7.4 PET Images; 7.5 Respiratory Gating; 7.6 Recent Developments; References; 8: Lung Cancer Pictorial Atlas; 8.1 Case 1: Lung Cancer and Tuberculosis; 8.2 Case 2: Mass-Like Lesions of Tuberculosis and Lung Cancer; 8.3 Case 3: Various Appearances of Adenocarcinoma In Situ: AIS (Bronchioloalveolar Carcinoma, BAC); 8.4 Case 4: Use of PET to Direct the Appropriate Site of Biopsy
3.2 Diagnosis3.3 Radiological Diagnosis; 3.4 Pathologic Diagnosis; 3.5 Staging; 3.6 Lung Cancer Staging System [9] (Table 3.1); 3.7 Management; 3.7.1 Early-Stage Lung Cancer; 3.7.1.1 Surgery; 3.7.1.2 Nonsurgical Management; Radiotherapy and Stereotactic Body Radiotherapy (SBRT); Radiofrequency Ablation; Adjuvant Chemotherapy; Adjuvant Radiotherapy; 3.7.2 Management of N2 Disease; 3.7.3 Management of Locally Advanced Unresectable Lung Cancer; 3.7.4 Management of Stage IV Disease; 3.7.5 Small Cell Lung Cancer; References; 4: Radiological Imaging in Lung Cancer
4.1 Introduction4.2 Imaging of the Primary Tumour; 4.2.1 CT Features of Mediastinal Invasion on CT; 4.2.2 Superior Sulcus Tumours (Pancoastâ#x80;#x99;s Tumours); 4.3 Imaging of Nodal Disease; 4.3.1 Nodal Sampling; 4.4 Imaging of Metastatic Disease; 4.5 Restaging of Tumours; 4.6 Imaging of Recurrent Disease; References; 5: 18F-FDG PET/CT in Lung Cancer; 5.1 Introduction; 5.2 Role of 18F-FDG PET/CT in the Evaluation of Solitary Pulmonary Nodule; 5.3 Staging of NSCLC; 5.3.1 T Staging; 5.3.2 N Staging; 5.3.3 M Staging; 5.4 Radiotherapy (RT) Planning
5.5 Prediction of Response and Treatment Response Evaluation5.6 Restaging/Recurrence; 5.7 Prognostication; 5.8 Small Cell Lung Cancer (SCLC); References; 6: 18F-FDG PET/CT: Normal Variants, Artifacts, and Pitfalls in Lung Cancer; 6.1 Introduction; 6.2 Normal Variants, Artifacts, and Pitfalls in Lung Cancer; 6.2.1 Technical Artifacts; 6.2.2 Various False Positives Due to Infection and Inflammation; 6.2.3 Incidental Findings; 6.2.3.1 Asymmetrical Vocal Cord Uptake; 6.2.4 Benign Etiologies Mimicking Distant Metastases in Lung Cancer
6.2.5 False-Negative Neoplastic PathologyReferences; 7: Physics of PET and Respiratory Gating; 7.1 PET Physics; 7.2 Reconstruction; 7.3 PET Tracers; 7.4 PET Images; 7.5 Respiratory Gating; 7.6 Recent Developments; References; 8: Lung Cancer Pictorial Atlas; 8.1 Case 1: Lung Cancer and Tuberculosis; 8.2 Case 2: Mass-Like Lesions of Tuberculosis and Lung Cancer; 8.3 Case 3: Various Appearances of Adenocarcinoma In Situ: AIS (Bronchioloalveolar Carcinoma, BAC); 8.4 Case 4: Use of PET to Direct the Appropriate Site of Biopsy